All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
Formulary
Back
Contact us about this page
Chapter 7: Obstetrics, gynaecology, and urinary-tract disorders
Toggle Parent Pages
Print this page
Contraception Guidance
Management of lower urinary tract symptoms (LUTS) in men
Management of urinary incontinence in women
Management of hypertension in pregnancy
Management of nausea and vomiting in pregnancy and hyperemesis gravidarum
Guidance on prescribing for erectile dysfunction
7.1 Drugs used in obstetrics
7.2 Treatment of vaginal and vulval conditions
7.3 Contraceptives
7.4 Drugs for genito-urinary disorders
Resources for: contraception for drugs with teratogenic potential, and prescribing in pregnancy and lactation
Contact us about this page
7.4.3 Drugs used in urological pain
First Line
Second Line
Specialist
Hospital Only
| SELF-CARE: NHS England has published guidance for various common conditions for which over the counter (OTC) items should not be routinely prescribed in primary care. One of these conditions is mild cystitis. Many products for mild cystitis are cheap to buy and are readily available OTC along with advice from pharmacies. Some self-care medicines are available from shops and supermarkets. |
Ascorbic acid (for acidification of urine) has not been included as the BNF classifies it as "less suitable for prescribing". The high doses that are required can lead to renal stones in those with hyperoxaluria.
Potassium citrate mixture BP
- Oral solution (£3.31 = 200ml) [OTC]
Indications
- Relief of discomfort in mild urinary-tract infections; alkalinisation of urine
Dose
- 10ml three times daily, well diluted with water
Notes
- The discomfort of cystitis may be relieved by alkalinisation of urine with potassium citrate.
Pentosan polysulfate sodium
- Capsules 100mg
Notes
- NICE TA610: Pentosan polysulfate sodium (Elmiron) is recommended as an option for treating bladder pain syndrome with glomerulations or Hunner's lesions in adults with urinary urgency and frequency, and moderate to severe pain, only when the criteria of the NICE TA are met (November 2019).
- MHRA Drug Safety Update (September 2019): Cases of pigmentary maculopathy leading to visual impairment have been reported with pentosan polysulfate, particularly after long-term use at high doses. Ensure patients taking pentosan polysulfate have regular ophthalmic examinations and ask them to promptly seek medical advice in case of visual changes.
